Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

VolitionRX Limited Common Stock (NY:VNRX)

0.4274 -0.0026 (-0.60%)
Streaming Delayed Price Updated: 2:29 PM EDT, May 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 439,422
Open 0.4300
Bid (Size) 0.4216 (22)
Ask (Size) 0.4274 (5)
Prev. Close 0.4300
Today's Range 0.3951 - 0.4502
52wk Range 0.4200 - 0.9000
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Earnings Scheduled For May 15, 2025
Via Benzinga
VolitionRX Earnings Preview
Via Benzinga

Performance

YTD
-32.2%
-32.2%
1 Month
-10.6%
-10.6%
3 Month
-27.9%
-27.9%
6 Month
-35.6%
-35.6%
1 Year
-42.8%
-42.8%

More News

Read More
Get insights into the top gainers and losers of Friday's after-hours session.
Via Chartmill
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
A Look Ahead: VolitionRX's Earnings Forecast
Via Benzinga
Earnings Preview For VolitionRX
Via Benzinga
This Weyerhaeuser Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Via Benzinga
Earnings Scheduled For March 31, 2025
Via Benzinga
Earnings Outlook For VolitionRX
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Life Sciences Virtual Investor Forum Agenda Announced for September 19th
From Virtual Investor Conferences
Via GlobeNewswire
VNRX Stock Earnings: VolitionRX Beats EPS, Misses Revenue for Q2 2024
Via InvestorPlace
Earnings Scheduled For November 14, 2024
Via Benzinga
BioMedNewsBreaks — VolitionRx Limited (NYSE American: VNRX) appoints PharmaVentures for Capture PCR(TM) and Oncology Portfolio Licensing
Via Investor Brand Network
BioMedNewsBreaks — VolitionRx Limited (NYSE American: VNRX) Highlights Latest Achievements in Mid-Year Review
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
Nexalin Technology and VolitionRX Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Via ACCESSWIRE
VNRX Stock Earnings: VolitionRX Beats EPS, Misses Revenue for Q1 2024
Via InvestorPlace
VolitionRx Ltd. (NYSE American: VNRX) Featured in Coverage of the EF Hutton Annual Global Conference
Via Investor Brand Network
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
VNRX Stock Earnings: VolitionRX Meets EPS, Misses Revenue for Q4 2023
Via InvestorPlace
Earnings Scheduled For March 25, 2024
Via Benzinga
Next Big Thing: 3  Biotech Stocks to Watch for Groundbreaking Advances
Via InvestorPlace
Topics Economy
Exposures Economy

Frequently Asked Questions

Is VolitionRX Limited Common Stock publicly traded?
Yes, VolitionRX Limited Common Stock is publicly traded.
What exchange does VolitionRX Limited Common Stock trade on?
VolitionRX Limited Common Stock trades on the New York Stock Exchange
What is the ticker symbol for VolitionRX Limited Common Stock?
The ticker symbol for VolitionRX Limited Common Stock is VNRX on the New York Stock Exchange
What is the current price of VolitionRX Limited Common Stock?
The current price of VolitionRX Limited Common Stock is 0.4274
When was VolitionRX Limited Common Stock last traded?
The last trade of VolitionRX Limited Common Stock was at 05/19/25 02:29 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.